GKOS vs. RMD: Glaukos vs. ResMed Stock Comparison
How do Glaukos (GKOS) and ResMed (RMD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Glaukos (GKOS) and ResMed (RMD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | GKOS | RMD |
|---|---|---|
| Name | Glaukos Corp. | ResMed Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 13.28 billion USD | 33.10 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | June 25, 2015 | June 2, 1995 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | GKOS | RMD |
|---|---|---|
| Total Return (1Y) | 179.91% | -5.42% |
| Total Return (3Y, Annualized) | 55.51% | 18.99% |
| Total Return (5Y, Annualized) | 35.14% | -1.23% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | GKOS | RMD |
|---|---|---|
| Volatility (1Y, Annualized) | 61.24% | 30.80% |
| Beta (5Y) | 0.68 | 0.75 |
| Max Drawdown (5Y) | -53.68% | -49.04% |
| Avg. Volume (3M) | 1.15M | 1.32M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | GKOS | RMD |
|---|---|---|
| Sharpe Ratio (1Y) | 2.87 | -0.31 |
| Sortino Ratio (1Y) | 5.93 | -0.43 |
Profitability
ROE (TTM)
Glaukos (GKOS) reports a negative ROE of -22.84%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile ResMed (RMD) reports 26.40%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-22.84%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- GKOS
- -22.84%
- Min
- -47.01%
RMD
Health Care Equipment & Services industry group
26.40%
- Max
- 47.61%
- RMD
- 26.40%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Glaukos (GKOS) reports a negative net margin of -24.60%, usually indicating a net loss over the period. Meanwhile ResMed (RMD) reports 27.79%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
-24.60%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- GKOS
- -24.60%
- Min
- -28.46%
RMD
Health Care Equipment & Services industry group
27.79%
- Max
- 29.35%
- RMD
- 27.79%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
ResMed (RMD) at 34.82% operates in the top operating margin quartile, ahead of Glaukos (GKOS) at 0.39%, which runs around its industry’s norm.
GKOS
Health Care Equipment & Services industry group
0.39%
- Max
- 35.43%
- Q3
- 14.14%
- Median
- 6.81%
- GKOS
- 0.39%
- Q1
- -0.28%
- Min
- -16.29%
RMD
Health Care Equipment & Services industry group
34.82%
- Max
- 35.43%
- RMD
- 34.82%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | GKOS | RMD |
|---|---|---|
| ROE (TTM) | -22.84% | 26.40% |
| ROA (TTM) | -3.90% | 14.76% |
| Net Margin (TTM) | -24.60% | 27.79% |
| Operating Margin (TTM) | 0.39% | 34.82% |
| Gross Margin (TTM) | 81.13% | 61.77% |
Growth
Revenue Growth
Glaukos (GKOS) at 32.33% sits in the top revenue growth quartile, while ResMed (RMD) at 9.85% is closer to the peer norm — faster top-line expansion for GKOS.
EPS Growth
Neither Glaukos (GKOS) nor ResMed (RMD) reports a EPS growth value for this period, so a direct comparison isn't possible.
Growth Metrics
| Metric | GKOS | RMD |
|---|---|---|
| Revenue Growth (YoY) | 32.33% | 9.85% |
| Revenue Growth (3Y CAGR) | 21.51% | 10.21% |
| EPS Growth (YoY) | -- | -- |
| EPS Growth (3Y CAGR) | -- | 19.64% |
Financial Strength
Current Ratio (MRQ)
ResMed (RMD) at 2.65 keeps current ratio within its industry’s typical mid-range, while Glaukos (GKOS) at 4.57 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
GKOS
Health Care Equipment & Services industry group
4.57
- Max
- 7.59
- GKOS
- 4.57
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
RMD
Health Care Equipment & Services industry group
2.65
- Max
- 7.59
- Q3
- 4.00
- RMD
- 2.65
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Glaukos (GKOS) at 0.15 and ResMed (RMD) at 0.10 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
GKOS
Health Care Equipment & Services industry group
0.15
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- GKOS
- 0.15
- Min
- 0.00
RMD
Health Care Equipment & Services industry group
0.10
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- RMD
- 0.10
- Min
- 0.00
Financial Strength Metrics
| Metric | GKOS | RMD |
|---|---|---|
| Current Ratio (MRQ) | 4.57 | 2.65 |
| Debt / Equity (MRQ) | 0.15 | 0.10 |
| Net Debt / EBITDA | -- | -0.19 |
Dividends
Dividend Yield (TTM)
Glaukos (GKOS) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a yield of 1.03%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
1.03%
- RMD
- 1.03%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Glaukos (GKOS) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile ResMed (RMD) reports a payout of 22.40%, ranking against industry peers normally.
GKOS
Health Care Equipment & Services industry group
0.00%
- GKOS
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
RMD
Health Care Equipment & Services industry group
22.40%
- RMD
- 22.40%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | GKOS | RMD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 1.03% |
| Dividend Payout Ratio (TTM) | 0.00% | 22.40% |
Valuation
P/E Ratio (TTM)
An earnings multiple is available for just one side: ResMed (RMD) trades at 21.43 times trailing earnings, ranked against its peers, while Glaukos (GKOS) has no P/E ratio this period.
GKOS
Health Care Equipment & Services industry group
--
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
- GKOS
- --
RMD
Health Care Equipment & Services industry group
21.43
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- RMD
- 21.43
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both look expensive on sales: ResMed (RMD) at 5.77 sits in the upper P/S ratio quartile, and Glaukos (GKOS) at 19.24 prices even higher, above its industry range.
GKOS
Health Care Equipment & Services industry group
19.24
- GKOS
- 19.24
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
RMD
Health Care Equipment & Services industry group
5.77
- Max
- 8.80
- RMD
- 5.77
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
ResMed (RMD) at 5.56 sits near its industry’s typical P/B ratio, while Glaukos (GKOS) at 18.51 prices above its benchmark range — GKOS looks rich relative to book.
GKOS
Health Care Equipment & Services industry group
18.51
- GKOS
- 18.51
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
RMD
Health Care Equipment & Services industry group
5.56
- Max
- 11.68
- Q3
- 6.12
- RMD
- 5.56
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | GKOS | RMD |
|---|---|---|
| P/E Ratio (TTM) | -- | 21.43 |
| P/S Ratio (TTM) | 19.24 | 5.77 |
| P/B Ratio (MRQ) | 18.51 | 5.56 |
| Free Cash Flow Yield (TTM) | 0.40% | 3.92% |